Dachaigh › Aillse a' bhroilleach › California › Santa Monica
Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Santa Monica, CA
Tha 28 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Santa Monica (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A’ fastadhÌre 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mìle air falbh
A Study of PHST001 in Advanced Solid Tumors
A’ fastadhÌre 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mìle air falbh
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
A’ fastadhÌre 2
- Beverly Hills Cancer Center, Beverly Hills · 6 mìle air falbh
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
A’ fastadhÌre 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A’ fastadh
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
A’ fastadhÌre 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6 mìle air falbh
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A’ fastadhÌre 3
- Clinical Trial Site, Beverly Hills · 6 mìle air falbh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
A’ fastadhÌre 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A’ fastadhÌre 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A’ fastadhÌre 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
A’ fastadhÌre 1/2
- Beverly Hills Cancer Center, Beverly Hills · 6 mìle air falbh
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A’ fastadhÌre 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A’ fastadhÌre 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 6 mìle air falbh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
A’ fastadhÌre 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
A’ fastadhÌre 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A’ fastadhÌre 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- agus 1 a bharrachd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A’ fastadhÌre 3
- Tower Cancer Research Foundation, Beverly Hills · 6 mìle air falbh
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mìle air falbh
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mìle air falbh
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
A’ fastadhÌre 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · 6 mìle air falbh
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
A’ fastadhÌre 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · 11 mìle air falbh
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A’ fastadhÌre 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
A’ fastadhÌre 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mìle air falbh
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
A’ fastadhÌre 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mìle air falbh
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mìle air falbh
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
A’ fastadhÌre 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
A’ fastadhÌre 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
A’ fastadhÌre 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mìle air falbh
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
A’ fastadhSgrùdadh amharc
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile
- New York City, NY136 sgrùdaidhean
- Houston, TX126 sgrùdaidhean
- Boston, MA112 sgrùdaidhean
- Nashville, TN81 sgrùdaidhean
- Los Angeles, CA73 sgrùdaidhean
- Edison, NJ68 sgrùdaidhean
- St. Louis, MO64 sgrùdaidhean
- Queens, NY64 sgrùdaidhean
- Durham, NC64 sgrùdaidhean
- Chicago, IL59 sgrùdaidhean
- Philadelphia, PA56 sgrùdaidhean
- Dallas, TX55 sgrùdaidhean
Sgrùdaidhean eile ann an Santa Monica
- Aillse Sgamhain Neo-chealla-beag45 sgrùdaidhean
- Aillse colorectal23 sgrùdaidhean
- Aillse (gach seòrsa)22 sgrùdaidhean
- Ailse metastatach19 sgrùdaidhean
- Ailseachadh nan Sgamhan15 sgrùdaidhean
- Cancer Ovarian15 sgrùdaidhean
- Aillse Prostata15 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil13 sgrùdaidhean
- Fàilligeadh a' Chridhe11 sgrùdadh
- Ailse Endometrial10 sgrùdaidhean
- Aillse a' Bhroinn9 sgrùdaidhean
- Cancer Pancreatic9 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.